---
$id: https://graph.org.ai/products/commodity/51332501
$type: Product
source: UNSPSC
code: "51332501"
title: "Haloperidol"
class: "51332500"
classTitle: "Antipsychotic butyrophenones"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Haloperidol

**UNSPSC Code**: 51332501
**Class**: [Antipsychotic butyrophenones](Antipsychotic butyrophenones.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a butyrophenone with the molecular formula C21H23ClFNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J6292F8L3D, chemically known as 1-butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)- but generally known as haloperidol, which bears US NIH Compound Identifier 3559. European Medicines Agency schedules Haloperidol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08005MIG. The term HALOPERIDOL is an International Non-Proprietary Name. World Health Organization schedules haloperidol in its Anatomical Therapeutic Chemical (ATC) Classification. HALOPERIDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule haloperidol under HS 29333999 and SITC 51574. As of Q4 2014, HALOPERIDOL remains the US FDA Preferred Term for this commodity. Haloperidol bears US NLM identifiers UMLS ID C0018546 and NCI Concept Code C537. SMILES: CLC1CCC(C2(O)CCN(CC2)CCCC(=O)C2CCC(F)CC2)CC1.

